By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

The Looming Copper Crunch: How a Critical Metal Shortfall Threatens Economic and Energy Security

Sex, Diet, and L-DOPA: A Risky Trio for Iron Accumulation in the Brain

Análisis de sensibilidad para la sismicidad inducida en acuíferos sedimentarios: lecciones para la geotermia de baja entalpía

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - The invisible burden: How air pollution’s metabolic fingerprints damage the heart

Medicine

The invisible burden: How air pollution’s metabolic fingerprints damage the heart

Last updated: March 1, 2026 12:33 pm
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

The invisible burden: How air pollution’s metabolic fingerprints damage the heart

An editorial in Heart draws a compelling parallel between historical fears of invisible plagues and the modern, unseen threat of ambient air pollution. It argues that fine particulate matter (PM2.5) and nitrogen oxides act as pervasive, insidious agents whose biological impact is now becoming visible through advanced metabolomic studies. These studies are beginning to trace the specific metabolic pathways—the “footprints”—through which air pollution contributes to the development and progression of heart failure, moving the threat from an abstract environmental hazard to a measurable physiological disruptor.

Why it might matter to you:
This framing elevates air pollution from a broad public health concern to a specific, biologically-grounded risk factor for a major chronic condition. For professionals focused on prevention, it underscores the need to integrate environmental data into risk stratification and patient education. It also highlights a potential avenue for more targeted interventions, as understanding the metabolic disruptions could lead to novel strategies for mitigating pollution’s cardiovascular effects.


Source →


Stay curious. Stay informed — with
Science Briefing.

Always double check the original article for accuracy.


Feedback

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article A Metabolic Axis for Progesterone: How NAD+ and SIRT1 Protect Ovarian Function
Next Article Unlocking Alzheimer’s in the Hispanic Population: A Genetic Matching Breakthrough
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

Superbugs at the pet–people boundary

Niacin’s Immune Modulation: A New Frontier in Glioblastoma Therapy

A novel prehospital pathway for procedural sedation in vulnerable patients

A new antiviral shows promise against severe H5N1 influenza

A disease’s hidden hand: how Chagas alters drug metabolism

A Framework for the Future of Genomic Newborn Screening

Plasma p-tau217: A Blood Test for Precision Alzheimer’s Disease Staging

image
Medicine

Libevitug approved in China as first-in-class treatment for hepatitis D

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Gastroenterology
  • Surgery
  • Engineering
  • Natural Language Processing
  • Chemistry
  • Cell Biology
  • Genetics

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?